NSE - Delayed Quote INR

COHANCE LIFESCIENCES LTD (COHANCE.NS)

1,027.00
-28.10
(-2.66%)
At close: 3:30:02 PM GMT+5:30
Currency in INR All numbers in thousands
Download
Breakdown
TTM
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Total Revenue
10,329,865
--
10,513,500
13,311,101
13,070,108
Cost of Revenue
--
--
4,485,106
5,861,949
5,722,929
Gross Profit
6,444,959
--
5,873,359
7,449,152
7,347,179
Operating Expense
3,339,033
--
2,325,533
2,186,149
1,915,189
Operating Income
3,105,926
--
3,547,826
5,263,003
5,431,990
Net Non Operating Interest Income Expense
-123,500
--
-54,357
-69,793
-84,589
Pretax Income
3,631,715
--
4,056,700
5,597,298
6,675,898
Tax Provision
837,611
--
1,053,911
1,484,395
2,137,850
Net Income Common Stockholders
2,792,305
--
3,002,805
4,112,900
4,538,049
Diluted NI Available to Com Stockholders
2,792,305
--
3,002,805
4,112,900
4,538,049
Basic EPS
10.97
--
11.80
16.16
17.83
Diluted EPS
10.93
--
11.80
16.16
17.83
Basic Average Shares
254,630.36
--
254,474.58
254,564.96
254,565
Diluted Average Shares
255,495.48
--
254,564.96
254,564.96
254,565
Rent Expense Supplemental
--
--
9,743
0
61
Total Expenses
7,223,939
--
6,810,639
8,048,098
7,638,118
Net Income from Continuing & Discontinued Operation
2,792,305
--
3,002,805
4,112,900
4,538,049
Normalized Income
2,429,074.52
--
3,002,800
3,980,528.45
4,033,538.28
Interest Income
--
--
20,154
58,316
686
Interest Expense
89,011
--
74,511
128,109
62,310
Net Interest Income
-68,857
--
-54,357
-69,793
-84,589
EBIT
3,720,726
--
4,131,200
5,725,407
6,738,208
EBITDA
4,399,350
--
4,676,250
6,205,271
7,129,180
Reconciled Cost of Revenue
--
--
4,485,106
5,861,949
5,722,929
Reconciled Depreciation
678,624
--
518,059
464,599
382,550
Net Income from Continuing Operation Net Minority Interest
2,792,305
--
3,002,805
4,112,900
4,538,049
Total Unusual Items Excluding Goodwill
472,119
--
472,119
180,146
742,183
Total Unusual Items
472,119
--
472,119
180,146
742,183
Normalized EBITDA
3,927,231
--
4,204,131
6,025,125
6,386,997
Tax Rate for Calcs
0
--
0
0
0
Tax Effect of Unusual Items
108,888.52
--
122,653.77
47,774.45
237,672.28
3/31/2022 - 5/8/2025

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

GLENMARK.BO Glenmark Pharmaceuticals Limited
1,598.45
+0.53%
 
ERIS.NS Eris Lifesciences Limited
1,636.40
-0.12%
 
CAPLIPOINT.NS Caplin Point Laboratories Limited
2,051.10
-2.02%
 
SHILPAMED.NS Shilpa Medicare Limited
921.75
+0.80%
 
SUVEN.NS Suven Life Sciences Limited
222.16
+0.44%
 
LAURUSLABS.NS Laurus Labs Limited
667.35
+3.94%
 
ABBOTINDIA.NS Abbott India Limited
31,810.00
+0.57%
 
GRANULES.NS Granules India Limited
536.60
+1.25%
 
AARTIDRUGS.NS Aarti Drugs Limited
468.50
+1.37%
 
DRREDDY.BO Dr. Reddy's Laboratories Limited
1,319.30
-0.09%